Predictive Oncology Inc
NASDAQ:POAI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Predictive Oncology Inc
NASDAQ:POAI
|
US |
|
S
|
Shanxi Antai Group Co Ltd
SSE:600408
|
CN |
|
U
|
U-Tech Co Ltd
KOSDAQ:178780
|
KR |
|
Jetblack Corp
OTC:JTBK
|
US |
|
C
|
China Huirong Financial Holdings Ltd
HKEX:1290
|
CN |
|
I
|
Inswave Systems Co Ltd
KOSDAQ:450520
|
KR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is POAI's stock price target?
Not Available
POAI doesn't have any price targets made by Wall Street professionals.
What is Predictive Oncology Inc's Revenue forecast?
Projected CAGR
147%
For the last 13 years the
compound annual growth rate for
Predictive Oncology Inc's revenue is
24%.
The projected
CAGR
for the next 3 years is
147%.